Gadobutrol Deemed Safe in Early Analysis

CHICAGO (MedPage Today) — A new MRI contrast agent, gadobutrol, was well-tolerated and safe according to results in more than 15,000 patients, researchers said here.

Post a Comment

Comments are closed.